Delivery Order SPE2DB20D1100-SPE2DB24FA2K7

Award Date 2/14/24
Potential Completion Date 2/15/24
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563790325 - Ondansetron ODT 8 mg Tablet 30s. The contract has a potential value of $2,603.40 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this delivery order. This award is part of...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets. The contract has a potential value of $1,189.79 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and operates out of its Corporate Office division in Conshohocken, Pennsylvania. This delivery order is part of a larger...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,734.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 8 mg tablets. The contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ondansetron ODT 4 mg tablets. The contract has a potential value of $1,721.02 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, provides pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery order...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, located in Conshohocken, Pennsylvania. The contract is for the provision of Ondansetron ODT 4mg tablets, with a completion date of February 22, 2024 and a potential value of $1,098.91. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor to DLA Troop Support Medical, providing a wide range of...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $6,133.89 contract is for the provision of Ondansetron ODT 4 mg tablets and has a completion date of January 30, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, has been awarded numerous similar contracts by DLA to supply pharmaceuticals,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,168,881 ondansetron ODT 8 mg tablets in 30-count packages. The $1,447.17 delivery order, with a completion date of December 26, 2023, was issued against an existing contract and does not have a set-aside designation. Amerisourcebergen Drug Corp provides pharmaceutical products and services to U.S....
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $22,012.59 to provide Ondansetron ODT 4 mg tablets. The contract has a performance period through January 31, 2024 and was not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) valued up...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,668.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to support the Department of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,751.81 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563891985 Ondansetron ODT 4 mg tablets. This delivery order contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA2K7
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,558.71 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ondansetron ODT 8 mg tablets. This contract has a completion date of February 15, 2024 and was awarded on February 14, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a for-profit prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.

Generated 5/19/24, 12:26 AM